Moreover, RES dose-dependently decreased the expression of β-catenin, p-GSK-3β (Ser9), and Myc and inhibited Wnt/β-catenin signaling in vivo, which increased the lifespan of mice and prevented the growth of LC. The gene discussed is GSK3B; the disease is laryngotracheoesophageal cleft.